Overview
Top Medical Research Studies
Over 12 weeks, participants took various doses of omega-3s, including EPA and DHA, revealing notable benefits. Those receiving higher doses of EPA and DHA saw their triglycerides drop significantly—by up to 15.78%—compared to controls.
Interestingly, ALA supplementation did not lead to improvements in cholesterol or inflammation status, highlighting the superior role of EPA and DHA in managing these health issues.
Remarkably, the scallop oil group showed a significant reduction in cholesterol levels in both serum and liver, while the fish oil and krill oil groups did not exhibit such benefits. The findings suggest that scallop oil might be a promising option for managing cholesterol and preventing related health issues.
In our study, rats that shifted to an n-3PUFA diet saw a notable decrease in serum lipids. While the diet appeared to positively impact their bone loss linked to periodontitis, rats on the n-3PUFA diet showed results similar to those on a commercial diet, indicating no major advantage of fish oil over a balanced diet.
Overall, our findings suggest that while omega-3s can help with cholesterol, they don't offer significant improvements over typical diets in these conditions.
Most Useful Reviews
Medical Researches
- All Researches
While a high-fat diet usually worsens cholesterol levels, ESKO demonstrated a protective effect by reducing fat accumulation and promoting better metabolic health. This suggests that krill oil could be a promising option for managing high cholesterol and obesity-related issues.
The results showed a significant reduction in cholesterol levels in rodents that consumed CA-rich oils. However, it’s important to note that the risk of bias in the studies varied, making our conclusions tentative. Overall, these findings suggest CA-rich fish oils could play a beneficial role in heart health, but further research in humans is needed.
Remarkably, the scallop oil group showed a significant reduction in cholesterol levels in both serum and liver, while the fish oil and krill oil groups did not exhibit such benefits. The findings suggest that scallop oil might be a promising option for managing cholesterol and preventing related health issues.
Importantly, while EPA proved effective, mixed omega-3 products lacking substantial evidence for heart health did not provide the same benefits. We believe adding EPA-only formulations to cardiovascular prevention guidelines is essential for at-risk individuals.
Over eighteen weeks, mice on a high-cholesterol diet receiving 8-HEPE showed significantly higher levels of good HDL cholesterol, alongside lower levels of bad LDL cholesterol and liver triglycerides.
This suggests that 8-HEPE may enhance lipid profiles and liver health by influencing certain genes in macrophages. While promising, further research is needed to confirm these benefits in humans.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
High cholesterol, or hyperlipidemia, is a medical condition characterized by an elevated level of cholesterol in the bloodstream. Cholesterol is a waxy, fat-like substance that’s essential for building healthy cells, but too much of it can lead to serious health issues, including heart disease and stroke. Cholesterol is carried through the blood by lipoproteins, with two main types being low-density lipoprotein (LDL) and high-density lipoprotein (HDL). LDL, often referred to as "bad" cholesterol, can lead to the buildup of plaque in the arteries, while HDL, known as "good" cholesterol, helps carry cholesterol away from the arteries and back to the liver.
Factors contributing to high cholesterol can include poor diet, lack of exercise, obesity, smoking, and genetic predisposition. Regular health screenings are crucial, as high cholesterol often presents no overt symptoms. Maintaining a heart-healthy diet rich in fruits, vegetables, whole grains, and healthy fats, coupled with regular physical activity and avoiding tobacco, can help manage cholesterol levels effectively. In some cases, medications may be necessary to control high cholesterol, so consulting with a healthcare provider is key for tailored advice.
Omega-3 fish oil is a nutritional supplement derived from the fatty tissues of fish, particularly fatty fish like salmon, mackerel, and sardines. It is rich in omega-3 fatty acids, which are essential fats that the body cannot produce on its own. The most significant types of omega-3s found in fish oil are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), both of which are known for their numerous health benefits. These include reducing inflammation, supporting heart health, and promoting brain function.
Incorporating omega-3 fish oil into your diet can be beneficial if you don’t consume enough fish regularly. Many health experts recommend oily fish as a part of a balanced diet due to their high omega-3 content. For those who find it difficult to include fish in their meals, fish oil supplements can offer a convenient alternative, providing the same essential fatty acids in concentrated form. However, it’s essential to choose high-quality supplements that are third-party tested for purity and potency to avoid contaminants such as heavy metals or other toxins that can impact health.
Omega-3 fish oil has been widely discussed for its potential benefits in managing cardiovascular health, including high cholesterol. Research indicates that omega-3 fatty acids, particularly EPA and DHA found in fish oil, can help lower triglyceride levels—a type of fat in the blood that contributes to high cholesterol. In some cases, these fatty acids may also raise levels of HDL (high-density lipoprotein), often referred to as "good" cholesterol. However, while omega-3s can be a beneficial part of a heart-healthy diet, they are not a stand-alone solution for cholesterol management.
It's essential to understand that fish oil supplementation should not replace standard cholesterol-lowering medications or lifestyle changes like diet and exercise. Consult with a healthcare professional before adding omega-3 supplements to your regimen, especially if you have existing health conditions or are taking other medications. Keeping a balanced diet rich in omega-3s from sources like fatty fish, flaxseeds, and walnuts can also support overall health and align with cholesterol management goals.
Based on various user reviews, the timeline for seeing results from taking an Omega-3 supplement for high cholesterol tends to vary. Many users report positive results over a period of weeks to months. For instance, one user mentioned that after taking the supplement regularly, their high cholesterol normalised over time (Read Review). Another user felt benefits and noticed improvements after a consistent period (Read Review).
However, results may not be guaranteed for everyone within the same timeframe. For example, one user shared that despite taking the omega for three months, their cholesterol tests had not shown improvement (Read Review). Therefore, while many have found success within months, individual results can vary significantly. It’s always advisable to consult with a healthcare professional to personalize your supplement routine.
Research supports the use of various omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in managing high cholesterol levels. A number of studies suggest that EPA can significantly lower triglyceride levels and improve overall cholesterol profiles. For instance, one research piece found that individuals taking a highly purified EPA formulation experienced notable reductions in total cholesterol and triglycerides, making a case for its effectiveness in high-risk cardiovascular patients [28]. Additionally, evidence from several sources indicates that EPA may also help lower the levels of low-density lipoprotein (LDL) cholesterol, which is linked to cardiovascular disease [24].
Furthermore, specific forms of krill oil have been shown to improve cholesterol metabolism and reduce fat accumulation in mice studies [38]. Another study highlighted the benefits of DHA, which not only aids in raising beneficial high-density lipoprotein (HDL) cholesterol but also appears to improve HDL's functionality in cholesterol transport [45]. It's important to note that while many results are promising, additional research, particularly involving human subjects, is necessary to fully understand the potential impact of omega-3s on cholesterol management. Overall, these findings suggest that omega-3 fatty acids, especially EPA and DHA, may be beneficial for individuals looking to address high cholesterol levels.
Based on user reviews, many individuals have reported significant improvements in their cholesterol levels after incorporating this Omega-3 supplement into their daily regimen. For example, one user noted that their high cholesterol normalized over time, indicating a positive outcome from consistent use of the product (Read Review). Other users echoed similar sentiments, stating that after regular consumption, they experienced not only reductions in cholesterol but also enhancements in heart health and inflammation management (Read Review).
Several reviewers emphasized the product's quality, highlighting that it effectively supports reduced cholesterol levels while being easy to swallow and having a pleasant taste (Read Review). However, it's worth mentioning that results can vary significantly among individuals. One user experienced no improvements after three months of use (Read Review). Therefore, while many have benefited from the supplement, individual responses to Omega-3 can differ based on various factors.
Based on user reviews, many individuals have reported positive outcomes when combining this Omega-3 supplement with other health routines to manage high cholesterol. Several users shared that while taking the supplement, they also focused on maintaining a healthy diet and exercise regimen, which seemed to amplify the cholesterol-lowering effects (Read Review). For instance, one user noted improvements in their overall health, attributing benefits not only to the Omega-3 but also to their lifestyle choices (Read Review).
However, not all experiences were the same. Some users, despite taking the Omega-3 consistently, did not see improvements in their cholesterol levels, suggesting that individual results may vary widely due to different factors, including genetic predispositions or other pre-existing health conditions (Read Review). Overall, while many users found the Omega-3 supplement beneficial for cholesterol management, they emphasized the importance of a holistic approach to health that includes dietary and lifestyle considerations.
Recent studies have shown that the optimal dosage of Omega-3 fish oil, particularly in the form of eicosapentaenoic acid (EPA), for managing high cholesterol can vary but often centers around 4 grams daily. This dosage is notably effective for patients at high risk for cardiovascular diseases, especially those with elevated triglyceride levels. In one clinical trial, 226 participants taking 4 grams of EPA daily observed significant improvements in their cholesterol levels, including reductions in triglycerides and low-density lipoprotein (LDL) cholesterol within just three months [28]. Moreover, the intensively examined icosapent ethyl formulation has been linked to considerable reductions in cardiovascular events for high-risk patients, notably showing potential even in well-controlled cholesterol settings [12].
It's essential to note that while high doses of EPA and docosahexaenoic acid (DHA) are often highlighted for their benefits, the individual responses can vary based on specific health conditions like diabetes or existing cardiovascular issues [33]. For those considering Omega-3 supplementation, it’s advisable to consult with a healthcare provider to determine personal needs and the best course of action.
Participants received 4 grams of EPA daily for three months alongside regular nutritional counseling. By tracking key health markers, we noted significant improvements in cholesterol levels, particularly in triglycerides and low-density lipoprotein (LDL). For instance, triglyceride levels dropped from an average of 2.97 mmol/L to 1.75 mmol/L in just three months.
Additionally, we found improvements in other important metrics, including total cholesterol and glucose levels, indicating that EPA supplementation may have broad benefits for cardiometabolic health. Although apolipoprotein A levels did not change significantly, the overall trend suggests that incorporating EPA could play a role in achieving better heart health outcomes.
While previous studies have shown mixed results regarding the effectiveness of triglyceride-lowering medications, EPA stands out in providing favorable outcomes for certain patient groups. It's worth noting that the combination of EPA with another substance, docosahexaenoic acid (DHA), has not demonstrated the same benefits.
The key takeaway is that while the search for efficient treatments continues, isolated EPA treatment has shown promise in reducing ASCVD risk, especially for patients struggling with high triglyceride levels. This suggests that as we develop our understanding of cholesterol management, EPA could be an important piece of the puzzle for those at risk.
We observed that when these mice were supplemented with krill oil, there were notable reductions in cholesterol levels and fat accumulation. It seemed to positively influence various metabolic pathways, such as those associated with cholesterol metabolism.
Specifically, DHA, along with other nutrients found in krill oil, appears to aid in lowering oxidative stress and improving cholesterol metabolism. While the benefits of DHA alone weren't isolated in this study, the overall findings suggest that krill oil may work effectively in reducing the risks tied to obesity and high cholesterol.
Overall, this research indicates that incorporating krill oil into our diets could be a promising strategy for managing cholesterol levels and supporting heart health.
Our results indicated that fish oil supplementation led to significant modifications in the proteins and lipid content of HDL. Notably, there was an increase in beneficial phospholipid families, such as sphingomyelins and phosphatidylcholines, which are crucial for HDL's role in cholesterol transport. We found that the capacity of HDL to efflux cholesterol, which is essential for heart health, increased after taking fish oil.
Additionally, improvements in HDL cholesterol efflux capacity were correlated with higher levels of EPA in the participants' blood. These findings suggest that DHA, through its role in fish oil, enhances HDL's ability to remove cholesterol, potentially offering cardiovascular benefits. Overall, our study highlights the transformative effects of fish oil on HDL and its cholesterol management capabilities.
This means that those at risk saw meaningful benefits from this treatment. Overall, we found that icosapent ethyl could be a valuable option for improving heart health in patients struggling with high cholesterol and triglycerides.
The study involved 150 patients with CAD, focusing on their serum levels of omega-3 fatty acids and their ability to maintain healthy endothelial function through a measurement called flow-mediated dilation (FMD). While we noted an association between DHA levels and endothelial dysfunction, the findings indicated that DHA alone was not assessed separately; rather, it was evaluated in tandem with EPA.
Interestingly, when we administered additional EPA to patients who had low EPA/arachidonic acid (AA) levels, there was a notable improvement in their endothelial function after three months. However, our observations suggested that while DHA levels were related to overall endothelial health, the study did not quantify the specific impact of DHA alone on cholesterol levels, leaving some questions unanswered. This highlights the complexity of omega-3 fatty acids’ effects in managing high cholesterol.
References
- Choi JH, Park SE, Kim S. Antarctic Krill Oil Supplementation Attenuates Hypercholesterolemia, Fatty Liver, and Oxidative Stress in Diet-Induced Obese Mice. Nutrients. 2024;16. doi:10.3390/nu16213614
- Hirako S, Kim H, Iizuka Y, Matsumoto A. Fish oil consumption prevents hepatic lipid accumulation induced by high-cholesterol feeding in obese KK mice. Biomed Res. 2024;45:33. doi:10.2220/biomedres.45.33
- Mjaatveit M, Oldernes H, Gudbrandsen OA. Effects of diets containing fish oils or fish oil concentrates with high cetoleic acid content on the circulating cholesterol concentration in rodents. A systematic review and meta-analysis. Br J Nutr. 2024;131:606. doi:10.1017/S0007114523002118
- Zhang C, Wang X, Sun S, Fu Y, Wu Y, et al. Fat-1 expression alleviates atherosclerosis in transgenic rabbits. J Cell Mol Med. 2022;26:1306. doi:10.1111/jcmm.17188
- Sugimoto K, Hosomi R, Shimono T, Kanda S, Nishiyama T, et al. Comparison of the Cholesterol-Lowering Effect of Scallop Oil Prepared from the Internal Organs of the Japanese Giant Scallop (Patinopecten yessoensis), Fish Oil, and Krill Oil in Obese Type II Diabetic KK-A Mice. J Oleo Sci. 2021;70:965. doi:10.5650/jos.ess21032
- Jaca A, Durão S, Harbron J. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. S Afr Med J. 2020;110:1158. doi:10.7196/SAMJ.2020.v110i12.14730
- Trivedi K, Le V, Nelson JR. The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention. Postgrad Med. 2021;133:28. doi:10.1080/00325481.2020.1783937
- Saito M, Ishida N, Yamada H, Ibi M, Hirose M. 8-HEPE-Concentrated Materials from Pacific Krill Improve Plasma Cholesterol Levels and Hepatic Steatosis in High Cholesterol Diet-Fed Low-Density Lipoprotein (LDL) Receptor-Deficient Mice. Biol Pharm Bull. 2020;43:919. doi:10.1248/bpb.b20-00162
- Llop-Talaveron J, Badía-Tahull M, Lozano-Andreu T, Rigo-Bonnin R, Virgili-Casas N, et al. Phytosterolemia and γ-glutamyl transferase in adults with parenteral nutrition: Fish versus vegetal lipids: A randomized clinical trial. Nutrition. 2020;70:110587. doi:10.1016/j.nut.2019.110587
- Antona ME, Ramos C, Stranges A, Monteiro AF, Gonzales Chaves MM, et al. Fish oil diet effects on alveolar bone loss, in hypercholesterolemic rats. Arch Oral Biol. 2020;109:104553. doi:10.1016/j.archoralbio.2019.104553
- Zhou Q, Zhang Z, Wang P, Zhang B, Chen C, et al. EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Mol Nutr Food Res. 2019;63:e1801157. doi:10.1002/mnfr.201801157
- Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, et al. Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT. J Am Coll Cardiol. 2019;73:2791. doi:10.1016/j.jacc.2019.02.032
- Preston Mason R. New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease. Curr Atheroscler Rep. 2019;21:2. doi:10.1007/s11883-019-0762-1
- Vikøren LA, Drotningsvik A, Bergseth MT, Mjøs SA, Austgulen MH, et al. Intake of Baked Cod Fillet Resulted in Lower Serum Cholesterol and Higher Long Chain -3 PUFA Concentrations in Serum and Tissues in Hypercholesterolemic Obese Zucker fa/fa Rats. Nutrients. 2018;10. doi:10.3390/nu10070840
- Blom WAM, Koppenol WP, Hiemstra H, Stojakovic T, Scharnagl H, et al. A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia. Eur J Nutr. 2019;58:1615. doi:10.1007/s00394-018-1706-1
- Shen J, Rastogi R, Guan L, Li F, Du H, et al. Omega-3 fatty acid supplement reduces activation of NADPH oxidase in intracranial atherosclerosis stenosis. Neurol Res. 2018;40:499. doi:10.1080/01616412.2018.1451290
- Yunoki K, Matsumi H, Miyoshi T, Kubo M, Hata Y, et al. Clinical Significance of Serum Omega-3 Fatty Acids on Endothelial Function in Patients with Coronary Artery Disease Under Statin Therapy. J Cardiovasc Dev Dis. 2025;12. doi:10.3390/jcdd12020060
- Aggarwal R, Bhatt DL, Steg PG, Miller M, Brinton EA, et al. Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025;14:e038656. doi:10.1161/JAHA.124.038656
- Uthaiah NM, Venkataramareddy SR, Mudhol S, Sheikh AY. EPA-rich Nannochloropsis oceanica biomass regulates gut microbiota, alleviates inflammation and ameliorates liver fibrosis in rats. Food Res Int. 2025;202:115733. doi:10.1016/j.foodres.2025.115733
- Yoshikiyo K, Shimizu H, Nagato EG, Ishizuka S, Yamamoto T. Comparative Analysis of γ-Cyclodextrin, Perilla Oil, and Their Inclusion Complexes on Liver Injury and Dyslipidemia Associated with Elevated Gastrointestinal 12-Hydroxylated Bile Acid Levels. Molecules. 2025;30. doi:10.3390/molecules30020281
- Choi JH, Park SE, Kim S. Antarctic Krill Oil Supplementation Attenuates Hypercholesterolemia, Fatty Liver, and Oxidative Stress in Diet-Induced Obese Mice. Nutrients. 2024;16. doi:10.3390/nu16213614
- Lamantia V, Bissonnette S, Beaudry M, Cyr Y, Rosiers CD, et al. EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors. Sci Rep. 2024;14:27146. doi:10.1038/s41598-024-73672-6
- Choi GY, Calder PC. The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials. Front Nutr. 2024;11:1423228. doi:10.3389/fnut.2024.1423228
- Bashir B, Schofield J, Downie P, France M, Ashcroft DM, et al. Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia. Front Cardiovasc Med. 2024;11:1389106. doi:10.3389/fcvm.2024.1389106
- Lin YL, Wang CL, Chiang TI. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients. Front Nephrol. 2024;4:1365809. doi:10.3389/fneph.2024.1365809
- Omari M, Alkhalil M. Atherosclerosis Residual Lipid Risk-Overview of Existing and Future Pharmacotherapies. J Cardiovasc Dev Dis. 2024;11. doi:10.3390/jcdd11040126
- Szarek M, Bhatt DL, Miller M, Brinton EA, Jacobson TA, et al. Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl. J Am Coll Cardiol. 2024;83:1529. doi:10.1016/j.jacc.2024.02.016
- Liakos CI, Lanaras L, Bristianou M, Papadopoulos DP. Pleiotropic beneficial cardiometabolic actions of a high-purity eicosapentaenoic acid product in high cardiovascular risk individuals. Lipids. 2024;59:67. doi:10.1002/lipd.12391
- Ganuza E, Etomi EH, Olson M, Whisner CM. Omega-3 eicosapentaenoic polar-lipid rich extract from microalgae decreases plasma triglycerides and cholesterol in a real-world normolipidemic supplement consumer population. Front Nutr. 2024;11:1293909. doi:10.3389/fnut.2024.1293909
- Kobayashi Y, Fujikawa T, Haruna A, Kawano R, Ozawa M, et al. Omega-3 Fatty Acids Reduce Remnant-like Lipoprotein Cholesterol and Improve the Ankle-Brachial Index of Hemodialysis Patients with Dyslipidemia: A Pilot Study. Medicina (Kaunas). 2023;60. doi:10.3390/medicina60010075
- Mueller PA, Bergstrom P, Rosario S, Heard M, Pamir N. Fish Oil Supplementation Modifies the Proteome, Lipidome, and Function of High-Density Lipoprotein: Findings from a Trial in Young Healthy Adults. J Nutr. 2024;154:1130. doi:10.1016/j.tjnut.2024.01.007
- Kaur G, Mason RP, Steg PG, Bhatt DL. Omega-3 fatty acids for cardiovascular event lowering. Eur J Prev Cardiol. 2024;31:1005. doi:10.1093/eurjpc/zwae003
- Yunoki K, Matsumi H, Miyoshi T, Kubo M, Hata Y, et al. Clinical Significance of Serum Omega-3 Fatty Acids on Endothelial Function in Patients with Coronary Artery Disease Under Statin Therapy. J Cardiovasc Dev Dis. 2025;12. doi:10.3390/jcdd12020060
- Chang Y, Xuan Y, Zhang R, Ding X, Zeng Q, et al. Effects of Dietary Schizochytrium Algae as ω-3 PUFA Source on the Egg-Laying Quail Performance, Serum Indexes, and Egg Yolk Fatty Acids Contents. Animals (Basel). 2024;15. doi:10.3390/ani15010021
- Li J, Guo J, Yuen M, Yuen H, Peng Q. The comparative effects of ω-7 fatty acid-rich sea buckthorn oil and ω-3 fatty acid-rich DHA algal oil on improving high-fat diet-induced hyperlipidemia. Food Funct. 2025;16:1241. doi:10.1039/d4fo04961f
- Coelho-Júnior HJ, Álvarez-Bustos A, Picca A, Calvani R, Rodriguez-Mañas L, et al. Dietary Intake of Polyunsaturated Fatty Acids Is Associated with Blood Glucose and Diabetes in Community-Dwelling Older Adults. Nutrients. 2024;16. doi:10.3390/nu16234087
- Cabrita ARJ, Barroso C, Fontes-Sousa AP, Correia A, Teixeira L, et al. Assessing functional properties of diet protein hydrolysate and oil from fish waste on canine immune parameters, cardiac biomarkers, and fecal microbiota. Front Vet Sci. 2024;11:1449141. doi:10.3389/fvets.2024.1449141
- Choi JH, Park SE, Kim S. Antarctic Krill Oil Supplementation Attenuates Hypercholesterolemia, Fatty Liver, and Oxidative Stress in Diet-Induced Obese Mice. Nutrients. 2024;16. doi:10.3390/nu16213614
- Lamantia V, Bissonnette S, Beaudry M, Cyr Y, Rosiers CD, et al. EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors. Sci Rep. 2024;14:27146. doi:10.1038/s41598-024-73672-6
- Choi GY, Calder PC. The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials. Front Nutr. 2024;11:1423228. doi:10.3389/fnut.2024.1423228
- Zhang D, Wang Z, Guo S, Sun Y, Zhou D, et al. F-Fluorodeoxyglucose positron emission tomography/computed tomography imaging reveals the protective effect of docosahexaenoic acid on glucose metabolism by reducing brain 27-hydroxycholesterol. Exp Gerontol. 2024;196:112577. doi:10.1016/j.exger.2024.112577
- Zhao W, Wang Y, Li J, Chen T, Yin D, et al. Efficacy and safety of omega-3-acid ethyl acetate 90 capsules in severe hypertriglyceridemia: A randomized, controlled, multicenter study. Lipids. 2024;59:145. doi:10.1002/lipd.12406
- Li P, Khan S, Huang Y, Lu S, Zhou P, et al. Effect of Perilla seeds inclusion on the performance, egg quality characteristics, biochemical parameters and egg yolk fatty acid composition of laying hens. Trop Anim Health Prod. 2024;56:147. doi:10.1007/s11250-024-03983-3
- Kobayashi Y, Fujikawa T, Haruna A, Kawano R, Ozawa M, et al. Omega-3 Fatty Acids Reduce Remnant-like Lipoprotein Cholesterol and Improve the Ankle-Brachial Index of Hemodialysis Patients with Dyslipidemia: A Pilot Study. Medicina (Kaunas). 2023;60. doi:10.3390/medicina60010075
- Mueller PA, Bergstrom P, Rosario S, Heard M, Pamir N. Fish Oil Supplementation Modifies the Proteome, Lipidome, and Function of High-Density Lipoprotein: Findings from a Trial in Young Healthy Adults. J Nutr. 2024;154:1130. doi:10.1016/j.tjnut.2024.01.007
